GDF‐15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective

R Adela, SK Banerjee - Journal of diabetes research, 2015 - Wiley Online Library
Growth differentiation factor‐15 (GDF‐15) is a stress responsive cytokine. It is highly
expressed in cardiomyocytes, adipocytes, macrophages, endothelial cells, and vascular …

Calcific aortic stenosis: a disease of the valve and the myocardium

MR Dweck, NA Boon, DE Newby - Journal of the American College of …, 2012 - jacc.org
Although aortic stenosis is a common condition associated with major morbidity, mortality,
and health economic costs, there are currently no medical interventions capable of delaying …

The progression of hypertensive heart disease

MH Drazner - Circulation, 2011 - Am Heart Assoc
Hypertensive heart disease is a constellation of abnormalities that includes left ventricular
hypertrophy (LVH), systolic and diastolic dysfunction, and their clinical manifestations …

Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European …

RM Lang, LP Badano, V Mor-Avi… - European Heart …, 2015 - academic.oup.com
The rapid technological developments of the past decade and the changes in
echocardiographic practice brought about by these developments have resulted in the need …

A review of heart chamber segmentation for structural and functional analysis using cardiac magnetic resonance imaging

P Peng, K Lekadir, A Gooya, L Shao… - … Resonance Materials in …, 2016 - Springer
Cardiovascular magnetic resonance (CMR) has become a key imaging modality in clinical
cardiology practice due to its unique capabilities for non-invasive imaging of the cardiac …

Cardiac plasticity

JA Hill, EN Olson - New England Journal of Medicine, 2008 - Mass Medical Soc
This review explains how the heart responds to physiologic or pathologic conditions.
Exercise, pregnancy, and postnatal growth cause physiologic growth; neurohumoral …

Biomarkers of cardiovascular disease: molecular basis and practical considerations

RS Vasan - Circulation, 2006 - Am Heart Assoc
echocardiogram) may be expected to facilitate the identification of patients with chest pain of
an ischemic etiology (angina). In a patient presenting to the emergency department with …

Prognostic implications of left ventricular hypertrophy

BA Vakili, PM Okin, RB Devereux - American heart journal, 2001 - Elsevier
Background To date there has been no comprehensive review of the association between
left ventricular hypertrophy (LVH) at baseline and subsequent adverse clinical events …

Risk prediction is improved by adding markers of subclinical organ damage to SCORE

T Sehestedt, J Jeppesen, TW Hansen… - European heart …, 2010 - academic.oup.com
Aims It is unclear whether subclinical vascular damage adds significantly to Systemic
Coronary Risk Evaluation (SCORE) risk stratification in healthy subjects. Methods and …

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events

PM Okin, RB Devereux, S Jern, SE Kjeldsen, S Julius… - Jama, 2004 - jamanetwork.com
ContextElectrocardiographic left ventricular hypertrophy (LVH) is a strong predictor of
cardiovascular (CV) morbidity and mortality. However, the predictive value of changes in the …